Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,500,000
Closed -$160M 1079
2024
Q1
$160M Hold
1,500,000
0.17% 103
2023
Q4
$148M Hold
1,500,000
0.18% 101
2023
Q3
$156M Buy
+1,500,000
New +$167M 0.22% 80

Other funds holding MRNA

DZ Bank's MRNA Position: Q1 2026 in Review

DZ Bank reduced its Moderna (MRNA) stake by 49% in Q1 2026, selling an estimated $701K and leaving 15,361 shares worth $779K. The position accounts for ﹤0.01% of the portfolio, ranked #747.

DZ Bank first reported a position in MRNA in Q1 2021 and has held it in 21 quarters since. The position peaked at $23.1M in Q3 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • DZ Bank held 15,361 shares of Moderna worth $779K as of Q1 2026.
  • DZ Bank sold 15,023 Moderna shares in Q1 2026, an estimated $701K.
  • Moderna made up ﹤0.01% of DZ Bank's portfolio in Q1 2026, its #747 holding.
  • DZ Bank first reported a position in Moderna in Q1 2021 and has held it in 21 quarters since.
  • DZ Bank's Moderna position peaked at $23.1M in Q3 2021.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on DZ Bank's 13F filing for Q1 2026, filed 15 May 2026.